CompoAtlas

Bois de Velours avec Ginseng

Natural health product licensed in Canada

Licence holder
Velnor Inc.
NPN or DIN-HM
80038072
Status
Inactive licence
Licence date
5 December 2012
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Cervus elaphus

Source : Cervus elaphus

170 mgNot calculated
Panax quinquefolius

Source : Racine

85 mgNot calculated

Non-medicinal ingredients

Gélatine

PopulationAgeQuantity per servingFrequency
AdultesNot specified3 Capsule2 days

Uses authorised in Canada

Le Bois de Velours utilisé en Médecine traditionnelle chinoise, renforce l'énergie Yang des reins, revitalise l'énergie vitale et le sang, fortifie les tendons et les os, douleur bas du dos et genoux, fatigue, extrémités froides, faiblesse, douleur, raideur, maux de têtes. Le Ginseng d'Amérique est utilisé traditionnellement en herboristerie pour aider à soulager la nervosité (sédatif léger), à la digestion dans les cas de stress et au maintien du système immunitaire et est utilisé en herboristerie comme thérapie de soutien pour aider au contrôle du taux de glucose.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80038072

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Panax quinquefolius
    Read the warning, when it applies and the studies cited

    PANAX QUINQUEFOLIUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or digoxin (Brinker 2010; Dasgupta et al. 2007; Elmer et al. 2007; Yuan et al. 2004).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Dascalu et al. 2007; Vuksan et al. 2000a,b,c).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: All products except Glucose levels and Adaptogen - immune system.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line